IgG ELISA Kit for Chlamydia Trachomatis

Intended Uses: The recomWell Chlamydia trachomatis test is used to detect the pres-ence of IgG and IgA antibodies to the proteins MOMP, TARP and CPAF. This serological test provides information about the infection status, especially in the case of chronified, ascending or inapparent infections. IgA antibodies occur within 2 to 4 weeks, while IgG antibodies occur after approx. 4 weeks. While IgG antibody titres decrease only gradu-ally and may persist throughout life, IgA antibodies will disappear ap-proximately 6 months after the healing process (for example, following treatment with antibiotics). IgA antibodies can occur in primary, chronic and recurring infections, as can an increase in the IgG titres.

Principle of the Assay: Highly purified Chlamydia trachomatis antigens (MOMP, TARP and CPAF) are fixed in the cavities of the micro-titre plate.

Small volumes of IgG elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS191645 is a ready-to-use microwell, strip-or-full plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the IgG, ELISA Kit target analytes in biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing IgG. The ELISA analytical biochemical technique of the MBS191645 kit is based on IgG antibody-IgG antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect IgG antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, IgG. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).